| Product Name | NebuSelect™ Recombinant Human IFN alpha 1, hFc-tag |
|---|---|
| Catalog Number | NBL-242531 |
| Alias/Synonyms | IFN alpha 1; Interferon alpha-1/13;IFN-alpha-1/13;Interferon alpha-D;LeIF D; IFNalpha 1; IFN alpha1;IFNA1;IFN-alpha-1;Interferon alpha 1 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P01562 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242531-100ug | 100ug | Inquire | Inquire | |
| NBL-242531-1mg | 1mg | Inquire | Inquire | |
| NBL-242531-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human IFN alpha 1, hFc-tag
Catalog#:
NBL-242531
Description:
NebuSelect™ Recombinant Human IFN alpha 1, hFc-tag(Cat#NBL-242531) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Cys24-Glu189.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 46.14 kDa. Due to glycosylation, the protein migrates to 48-55 kDa based on Bis-Tris PAGE result.
Target Name:
IFN alpha 1; Interferon alpha-1/13;IFN-alpha-1/13;Interferon alpha-D;LeIF D; IFNalpha 1; IFN alpha1;IFNA1;IFN-alpha-1;Interferon alpha 1
Target Information:
IFN-α, a cytokine expressed in human islets from individuals affected by type 1 diabetes, plays a key role in the pathogenesis of diabetes by upregulating inflammation, endoplasmic reticulum (ER) stress and MHC class I overexpression, three hallmarks of islet histology in early type 1 diabetes.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.